{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:08:13Z","timestamp":1780312093906,"version":"3.54.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"DOI":"10.7759\/cureus.110031","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:40:00Z","timestamp":1780310400000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Body Mass Index With Mortality and Clinical Outcomes in Patients With Nonalcoholic Fatty Liver Disease: A Medical Information Mart for Intensive Care IV (MIMIC-IV) Cohort Study"],"prefix":"10.7759","author":[{"given":"Miracle C","family":"Chukwuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abidemi O","family":"Akinrinmade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhakshayani G","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A","family":"Gbigbi-Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Redvers","family":"Kadzungwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkechi R","family":"Ihezie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adewale A","family":"Kuye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifunanya R","family":"Ekeocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaeze  E","family":"Uzozie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anulika","family":"Anyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/450639","article-title":"Nonalcoholic fatty liver disease, diabetes mellitus and cardiovascular disease: newer data","volume":"2013","author":"Mavrogiannaki AN","year":"2013","unstructured":"Mavrogiannaki AN, Migdalis IN. Nonalcoholic fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. Int J Endocrinol. 2013, 2013:450639. 10.1155\/2013\/450639","journal-title":"Int J Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels S","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, et al.. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022, 22:63. 10.1186\/s12902-022-00980-1","journal-title":"BMC Endocr Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice J","year":"2018","unstructured":"Maurice J, Manousou P. Non-alcoholic fatty liver disease. Clin Med (Lond). 2018, 18:245-50. 10.7861\/clinmedicine.18-3-245","journal-title":"Clin Med (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng ML","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ, et al.. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023, 29:S32-42. 10.3350\/cmh.2022.0365","journal-title":"Clin Mol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"Paik JM","year":"2023","unstructured":"Paik JM, Henry L, Younossi Y, Ong J, Alqahtani S, Younossi ZM. The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019. Hepatol Commun. 2023, 7:e0251. 10.1097\/HC9.0000000000000251","journal-title":"Hepatol Commun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies","volume":"101","author":"Loomis AK","year":"2016","unstructured":"Loomis AK, Kabadi S, Preiss D, et al.. Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies. J Clin Endocrinol Metab. 2016, 101:945-52. 10.1210\/jc.2015-3444","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung UJ","year":"2014","unstructured":"Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014, 15:6184-223. 10.3390\/ijms15046184","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1419715","article-title":"Body mass index and waist-to-height ratio effect on mortality in non-alcoholic fatty liver: revisiting the obesity paradox","volume":"15","author":"Jiang H","year":"2024","unstructured":"Jiang H, Li M, Yu H, Huang Y, Yang B, Wu B, Yang Y. Body mass index and waist-to-height ratio effect on mortality in non-alcoholic fatty liver: revisiting the obesity paradox. Front Endocrinol (Lausanne). 2024, 15:1419715. 10.3389\/fendo.2024.1419715","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12216765","article-title":"Does the \"obesity paradox\" have an expiration date? A retrospective cohort study","volume":"12","author":"Elkan M","year":"2023","unstructured":"Elkan M, Kofman N, Minha S, Rappoport N, Zaidenstein R, Koren R. Does the \"obesity paradox\" have an expiration date? A retrospective cohort study. J Clin Med. 2023, 12:6765. 10.3390\/jcm12216765","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04074-1","article-title":"The obesity paradox for survivors of critically ill patients","volume":"26","author":"Zhou D","year":"2022","unstructured":"Zhou D, Wang C, Lin Q, Li T. The obesity paradox for survivors of critically ill patients. Crit Care. 2022, 26:198. 10.1186\/s13054-022-04074-1","journal-title":"Crit Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82424-5","article-title":"Association between BMI and outcomes in critically ill patients: an analysis of the MIMIC-III database","volume":"14","author":"Yu W","year":"2024","unstructured":"Yu W, Jiang W, Yuan J, et al.. Association between BMI and outcomes in critically ill patients: an analysis of the MIMIC-III database. Sci Rep. 2024, 14:31127. 10.1038\/s41598-024-82424-5","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21037\/tgh-23-31","article-title":"Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review","volume":"9","author":"Njei B","year":"2024","unstructured":"Njei B, Al-Ajlouni YA, Ugwendum D, Abdu M, Forjindam A, Mohamed MF. Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review. Transl Gastroenterol Hepatol. 2024, 9:11. 10.21037\/tgh-23-31","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: a distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen F","year":"2020","unstructured":"Chen F, Esmaili S, Rogers GB, et al.. Lean NAFLD: a distinct entity shaped by differential metabolic adaptation. Hepatology. 2020, 71:1213-27. 10.1002\/hep.30908","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000920","article-title":"Metabolic dysfunction and nonalcoholic fatty liver disease risk in individuals with a normal body mass index","volume":"39","author":"DiStefano JK","year":"2023","unstructured":"DiStefano JK, Gerhard GS. Metabolic dysfunction and nonalcoholic fatty liver disease risk in individuals with a normal body mass index. Curr Opin Gastroenterol. 2023, 39:156-62. 10.1097\/MOG.0000000000000920","journal-title":"Curr Opin Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000471","article-title":"Severe obesity is associated with worse outcomes than lean metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Behari J","year":"2024","unstructured":"Behari J, Wang R, Luu HN, McKenzie D, Molinari M, Yuan JM. Severe obesity is associated with worse outcomes than lean metabolic dysfunction-associated steatotic liver disease. Hepatol Commun. 2024, 8:10.1097\/HC9.0000000000000471","journal-title":"Hepatol Commun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38550","article-title":"Trends of cardiovascular interventions stratified by body mass index: an analysis of the 2016-2020 nationwide inpatient sample population","volume":"15","author":"Evbayekha EO","year":"2023","unstructured":"Evbayekha EO, Aiwuyo HO, Obonna JC, et al.. Trends of cardiovascular interventions stratified by body mass index: an analysis of the 2016-2020 nationwide inpatient sample population. Cureus. 2023, 15:e38550. 10.7759\/cureus.38550","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s44158-026-00352-4","article-title":"The relationship between a lower body mass index and reintubation among critically ill patients: a multicenter retrospective cohort study","volume":"6","author":"Maezawa T","year":"2026","unstructured":"Maezawa T, Sakuraya M, Goto T. The relationship between a lower body mass index and reintubation among critically ill patients: a multicenter retrospective cohort study. J Anesth Analg Crit Care. 2026, 6:39. 10.1186\/s44158-026-00352-4","journal-title":"J Anesth Analg Crit Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13195737","article-title":"Impact of non-alcoholic fatty liver disease on sepsis inpatient outcomes: a nationwide sample analysis (2000-2019)","volume":"13","author":"Lyu X","year":"2024","unstructured":"Lyu X, Liu B, Li Y, et al.. Impact of non-alcoholic fatty liver disease on sepsis inpatient outcomes: a nationwide sample analysis (2000-2019). J Clin Med. 2024, 13:5737. 10.3390\/jcm13195737","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2019.0402","article-title":"Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States","volume":"32","author":"Adejumo AC","year":"2019","unstructured":"Adejumo AC, Samuel GO, Adegbala OM, et al.. Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States. Ann Gastroenterol. 2019, 32:504-13. 10.20524\/aog.2019.0402","journal-title":"Ann Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"Johnson AE","year":"2023","unstructured":"Johnson AE, Bulgarelli L, Shen L, et al.. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023, 10:1. 10.1038\/s41597-022-01899-x","journal-title":"Sci Data"},{"key":"ref21","unstructured":"MIMIC-IV. (2024). Accessed. 2026: https:\/\/physionet.org\/content\/mimiciv\/3.1\/."},{"key":"ref22","unstructured":"Stata Statistical Software. (2025). Accessed. April 5, 2026: https:\/\/www.stata.com\/stata18\/."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani N","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al.. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018, 67:328-57. 10.1002\/hep.29367","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al.. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023, 77:1797-835. 10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera L","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019, 156:1264-1281.e4. 10.1053\/j.gastro.2018.12.036","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.04.020","article-title":"New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD","volume":"71","author":"Boursier J","year":"2019","unstructured":"Boursier J, Guillaume M, Leroy V, et al.. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD. J Hepatol. 2019, 71:389-96. 10.1016\/j.jhep.2019.04.020","journal-title":"J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/497378-association-of-body-mass-index-with-mortality-and-clinical-outcomes-in-patients-with-nonalcoholic-fatty-liver-disease-a-medical-information-mart-for-intensive-care-iv-mimic-iv-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:40:03Z","timestamp":1780310403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/497378-association-of-body-mass-index-with-mortality-and-clinical-outcomes-in-patients-with-nonalcoholic-fatty-liver-disease-a-medical-information-mart-for-intensive-care-iv-mimic-iv-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.110031","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}